BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15162436)

  • 1. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells.
    Falco M; Marcenaro E; Romeo E; Bellora F; Marras D; Vély F; Ferracci G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 2004 Jun; 34(6):1663-72. PubMed ID: 15162436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
    Wu Z; Xu Y
    J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
    Gray JD; Hirokawa M; Ohtsuka K; Horwitz DA
    J Immunol; 1998 Mar; 160(5):2248-54. PubMed ID: 9498764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
    Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
    Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
    Cole MS; Anasetti C; Tso JY
    J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells.
    Tangye SG; Phillips JH; Lanier LL
    Semin Immunol; 2000 Apr; 12(2):149-57. PubMed ID: 10764623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific targeting of CD33(+) leukemia cells by a natural killer cell line modified with a chimeric receptor.
    Schirrmann T; Pecher G
    Leuk Res; 2005 Mar; 29(3):301-6. PubMed ID: 15661266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction.
    Welte S; Kuttruff S; Waldhauer I; Steinle A
    Nat Immunol; 2006 Dec; 7(12):1334-42. PubMed ID: 17057721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia.
    Steinbacher J; Baltz-Ghahremanpour K; Schmiedel BJ; Steinle A; Jung G; Kübler A; André MC; Grosse-Hovest L; Salih HR
    Int J Cancer; 2015 Mar; 136(5):1073-84. PubMed ID: 25046567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
    Marshall JD; Heeke DS; Abbate C; Yee P; Van Nest G
    Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
    Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
    Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
    Kwiatkowska EP; Kazimierczak U; Mackiewicz A; Kowalczyk DW
    Acta Biochim Pol; 2006; 53(2):361-9. PubMed ID: 16733563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of alpha-Gal on primary human endothelium does not confer susceptibility to NK cell cytotoxicity or increased NK cell adhesion.
    He Z; Ehrnfelt C; Kumagai-Braesch M; Islam KB; Holgersson J
    Eur J Immunol; 2004 Apr; 34(4):1185-95. PubMed ID: 15048730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.
    Lion E; Smits EL; Berneman ZN; Van Tendeloo VF
    J Immunol Methods; 2009 Oct; 350(1-2):89-96. PubMed ID: 19733573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
    Cederarv M; Söderberg-Nauclér C; Odeberg J
    Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro coculture model to study cytokine profiles of natural killer cells during maternal immune cell-trophoblast interactions.
    Ntrivalas E; Kwak-Kim J; Beaman K; Mantouvalos H; Gilman-Sachs A
    J Soc Gynecol Investig; 2006 Apr; 13(3):196-202. PubMed ID: 16516503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells.
    Zhang X; Wei H; Chen Q; Tian Z
    Oncol Rep; 2007 Jun; 17(6):1371-5. PubMed ID: 17487393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential.
    Terai M; Tamura Y; Alexeev V; Ohtsuka E; Berd D; Mastrangelo MJ; Sato T
    Cancer Immunol Immunother; 2009 Aug; 58(8):1307-17. PubMed ID: 19142637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.